TNF signaling gets FLIPped off: TNF-induced regulation of FLIP

Stuart A Rushworth1, Alison Taylor, Susana Langa

  • 1School of Chemical Sciences and Pharmacy, University of East Anglia, Norwich, United Kingdom.

Insights

FLIP protein regulates programmed cell death and apoptosis. Understanding how tumor necrosis factor (TNF) activates FLIP is vital for controlling cancer by modulating cell death pathways.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Immunology

Background:

  • The Fas-associated protein with death domain-like IL-1beta-converting enzyme (FLICE) inhibitory protein (FLIP) is a key regulator of programmed cell death.
  • FLIP modulates apoptosis in normal cells and confers resistance to death receptor-mediated apoptosis in tumor cells.
  • Dysregulation of FLIP is implicated in various diseases, including cancer.

Purpose of the Study:

  • To elucidate the mechanisms controlling FLIP activation by tumor necrosis factor (TNF).
  • To understand the functional significance of these regulatory mechanisms in apoptosis.
  • To provide insights into potential therapeutic strategies for cancer.

Main Methods:

  • The study discusses known mechanisms of FLIP regulation.
  • Focuses on signaling pathways initiated by TNF.
  • Reviews functional consequences of FLIP activation in apoptotic processes.

Main Results:

  • FLIP activation by TNF is a critical step in controlling apoptosis.
  • Specific signaling pathways downstream of TNF receptor engagement regulate FLIP.
  • These regulatory mechanisms influence cell survival and death decisions.

Conclusions:

  • Understanding TNF-mediated FLIP regulation is crucial for cancer research.
  • Targeting FLIP activation pathways may offer novel therapeutic avenues for cancer treatment.
  • FLIP's role in apoptosis highlights its importance in maintaining cellular homeostasis and disease progression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...